Vimarsana
Biggest News Aggregation in the World

Nathaniel Katz News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nathaniel Katz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nathaniel Katz Today - Breaking & Trending Today

Macro Environment Puts CFO Spotlight on Working Capital Cadence - Vimarsana News

Macro Environment Puts CFO Spotlight on Working Capital Cadence

When things spiral out of control, CFOs need to have the proper controls. That’s according to Nathaniel Katz, chief financial officer at eCommerce software…

Source: biztoc.com
Related Topics:
Nathaniel KatzReaking News
ROKT APPOINTS NATHANIEL KATZ AS CFO AS COMPANY ACCELERATES GROWTH - Vimarsana News

ROKT APPOINTS NATHANIEL KATZ AS CFO AS COMPANY ACCELERATES GROWTH

/PRNewswire/ -- Rokt, the leading ecommerce technology company using machine learning to make transactions more relevant to each shopper, today announced that...

Confo Therapeutics Establishes Medical Advisory Board - Vimarsana News

Confo Therapeutics Establishes Medical Advisory Board

Confo Therapeutics today announced the establishment of its Medical Advisory Board (MAB). The MAB will provide external review and strategic advice for the company's clinical development program including

04.12.21 -- Best Practices For Implementing Decentralized Clinical Trials - Vimarsana News

04.12.21 -- Best Practices For Implementing Decentralized Clinical Trials

04.12.21 -- Best Practices For Implementing Decentralized Clinical Trials   Sponsor Is clinical development prepared for the paradigm shift caused by COVID-19? The pandemic has forced the industry to reevaluate how to engage with patients and acquire patient data without direct, in-person access. Biopharmaceutical companies, medical device companies, and CROs from around the world were surveyed to explore the impact on clinical trials in this new paradigm and gain insights into their experiences operationalizing trials in a pandemic. Learn more. Featured Edi...

03.08.21 -- Appili's CRO Selection Reflects Realities Of Clinical Studies In A Pandemic - Vimarsana News

03.08.21 -- Appili's CRO Selection Reflects Realities Of Clinical Studies In A Pandemic

03.08.21 -- Appili's CRO Selection Reflects Realities Of Clinical Studies In A Pandemic     Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs.   Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more!   By Ed Miseta, chief editor, Clinical Leader When Appili Therapeutics was ready to enter a Phase 3 trial for a COVID-19 t...